AU2001242823A1 - Selective preventives/remedies for progressive lesions after organ damage - Google Patents
Selective preventives/remedies for progressive lesions after organ damageInfo
- Publication number
- AU2001242823A1 AU2001242823A1 AU2001242823A AU4282301A AU2001242823A1 AU 2001242823 A1 AU2001242823 A1 AU 2001242823A1 AU 2001242823 A AU2001242823 A AU 2001242823A AU 4282301 A AU4282301 A AU 4282301A AU 2001242823 A1 AU2001242823 A1 AU 2001242823A1
- Authority
- AU
- Australia
- Prior art keywords
- preventives
- remedies
- selective
- organ damage
- progressive lesions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000088990 | 2000-03-28 | ||
JP2000-88990 | 2000-03-28 | ||
JP2000289458 | 2000-09-22 | ||
JP2000-289458 | 2000-09-22 | ||
PCT/JP2001/002513 WO2001072730A1 (en) | 2000-03-28 | 2001-03-27 | Selective preventives/remedies for progressive lesions after organ damage |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001242823A1 true AU2001242823A1 (en) | 2001-10-08 |
Family
ID=26588576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001242823A Abandoned AU2001242823A1 (en) | 2000-03-28 | 2001-03-27 | Selective preventives/remedies for progressive lesions after organ damage |
Country Status (4)
Country | Link |
---|---|
US (2) | US6878745B2 (en) |
EP (1) | EP1277747A4 (en) |
AU (1) | AU2001242823A1 (en) |
WO (1) | WO2001072730A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060014709A1 (en) * | 2002-09-11 | 2006-01-19 | Michio Ishibashi | Drug or cosmetic |
JPWO2007142309A1 (en) * | 2006-06-09 | 2009-10-29 | 道男 石橋 | Screening method for renal glomerular therapeutic agent |
WO2008133036A1 (en) * | 2007-04-12 | 2008-11-06 | Michio Ishibashi | Method for screening of therapeutic agent for renal tubular dysfunction |
JP2012171907A (en) * | 2011-02-21 | 2012-09-10 | Nara Medical Univ | Medicine for repairing, regenerating and treating internal organ tissue by novel benzoisofranone derivative |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62228075A (en) * | 1985-04-30 | 1987-10-06 | Takeda Chem Ind Ltd | Antimicrobial compound, production and use thereof |
JP3122161B2 (en) * | 1991-05-16 | 2001-01-09 | 武田薬品工業株式会社 | γ-lactone immunosuppressant |
US5550132A (en) * | 1994-06-22 | 1996-08-27 | University Of North Carolina | Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines |
AU4426296A (en) * | 1994-08-11 | 1996-03-07 | Takeda Chemical Industries Ltd. | G protein coupled receptor protein, production, and use thereof |
US6165785A (en) * | 1996-05-24 | 2000-12-26 | University Of Cincinnati | Bone marrow cultures for developing suppressor and stimulator cells for research and therapeutic applications |
-
2001
- 2001-03-27 AU AU2001242823A patent/AU2001242823A1/en not_active Abandoned
- 2001-03-27 US US10/239,783 patent/US6878745B2/en not_active Expired - Fee Related
- 2001-03-27 EP EP01915865A patent/EP1277747A4/en not_active Withdrawn
- 2001-03-27 WO PCT/JP2001/002513 patent/WO2001072730A1/en active Application Filing
-
2005
- 2005-01-31 US US11/045,394 patent/US20050143453A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20030181506A1 (en) | 2003-09-25 |
EP1277747A4 (en) | 2009-07-29 |
EP1277747A1 (en) | 2003-01-22 |
US20050143453A1 (en) | 2005-06-30 |
US6878745B2 (en) | 2005-04-12 |
WO2001072730A1 (en) | 2001-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001246876A1 (en) | Remedies | |
AU2001246877A1 (en) | Remedies | |
AU2001286221A1 (en) | Remedies for ischemic diseases | |
AU8622101A (en) | Remedies for ischemic diseases | |
AU3919401A (en) | Starter | |
AU2002215116A1 (en) | Expander | |
AU2001290685A1 (en) | Methods for inhibiting inflammatory disease | |
AU2001283989A1 (en) | Surface-active photoinitiators | |
AU2001252599A1 (en) | Remedies for cancer | |
EP1151667A3 (en) | Plant-activating agent | |
AU2002224919A1 (en) | Surface-active photoinitiators | |
AU2001259702A1 (en) | Tissue regrafting | |
AU2002231669A1 (en) | Surface-active photoinitiators | |
AU2001277711A1 (en) | Remedies for cisplatin-tolerant cancer | |
AU2002210925A1 (en) | Preventives/remedies for portal hypertension | |
PT1344526E (en) | Preventives/remedies for inflammatory airway diseases | |
AU2002224596A1 (en) | Preventives or remedies for obesity or fatty liver | |
AU3987800A (en) | Preventives/remedies for angiostenosis | |
AU2001232271A1 (en) | Preventives/remedies for postoperative stress | |
AU2371201A (en) | Endoscope | |
AU2001236006A1 (en) | Preventives/remedies for kidney diseases | |
AU2002222676A1 (en) | Preventives or remedies for endometriosis | |
AU2001242823A1 (en) | Selective preventives/remedies for progressive lesions after organ damage | |
AU2002224133A1 (en) | Remedies for dermatophytosis | |
AU2001269336A1 (en) | Multiple expander |